Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP962894.RARxhKWruljxMor_MWhm5Dpk6Fw7nL3HIUtRTUoC2KvqI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP962894.RARxhKWruljxMor_MWhm5Dpk6Fw7nL3HIUtRTUoC2KvqI130_assertion type Assertion NP962894.RARxhKWruljxMor_MWhm5Dpk6Fw7nL3HIUtRTUoC2KvqI130_head.
- NP962894.RARxhKWruljxMor_MWhm5Dpk6Fw7nL3HIUtRTUoC2KvqI130_assertion description "[These findings may be clinically relevant in relation to the recent availability of active EGFR- and HER-2/neu-targeted pharmaceutical agents and to the extensively described negative prognostic significance of beta-HCG expression in mixed GCTs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP962894.RARxhKWruljxMor_MWhm5Dpk6Fw7nL3HIUtRTUoC2KvqI130_provenance.
- NP962894.RARxhKWruljxMor_MWhm5Dpk6Fw7nL3HIUtRTUoC2KvqI130_assertion evidence source_evidence_literature NP962894.RARxhKWruljxMor_MWhm5Dpk6Fw7nL3HIUtRTUoC2KvqI130_provenance.
- NP962894.RARxhKWruljxMor_MWhm5Dpk6Fw7nL3HIUtRTUoC2KvqI130_assertion SIO_000772 11555591 NP962894.RARxhKWruljxMor_MWhm5Dpk6Fw7nL3HIUtRTUoC2KvqI130_provenance.
- NP962894.RARxhKWruljxMor_MWhm5Dpk6Fw7nL3HIUtRTUoC2KvqI130_assertion wasDerivedFrom befree-20150227 NP962894.RARxhKWruljxMor_MWhm5Dpk6Fw7nL3HIUtRTUoC2KvqI130_provenance.
- NP962894.RARxhKWruljxMor_MWhm5Dpk6Fw7nL3HIUtRTUoC2KvqI130_assertion wasGeneratedBy ECO_0000203 NP962894.RARxhKWruljxMor_MWhm5Dpk6Fw7nL3HIUtRTUoC2KvqI130_provenance.